Relevance of NCH clinically relevant fusion ascertainment to "Select a tumour RNA fusion-detection workflow"
- Use case
- Select a tumour RNA fusion-detection workflow
- Assessed by
- NCH clinically relevant fusion ascertainment
- Relevance
- Direct evidence
- Endpoint
- Retrospective sensitivity among 67 ensemble-ascertained clinically relevant fusions in a 229-sample paediatric cancer/haematologic cohort, for STAR-Fusion and Arriba
A real clinical cohort with ensemble-ascertained clinically relevant fusions directly measures fusion-detection sensitivity in a clinical population, the declared endpoint; the ascertainment denominator is not an independent exhaustive truth set.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
15 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Retrospective sensitivity among 67 ensemble-ascertained clinically relevant fusions in a 229-sample paediatric cancer/haematologic cohort, for STAR-Fusion and Arriba Context-only references | Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:amp-oncology-rna-20261007-protocol-enfusion-nch-clinical Context-only references | Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations3 values
| Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records9 values
| Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale A real clinical cohort with ensemble-ascertained clinically relevant fusions directly measures fusion-detection sensitivity in a clinical population, the declared endpoint; the ascertainment denominator is not an independent exhaustive truth set. Context-only references | Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Reason Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365). Context-only references | Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relevance direct Context-only references | Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Revision 1 Context-only references | Discovery of clinically relevant fusions in pediatric cancer amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Discovery of clinically relevant fusions in pediatric cancer · Original source · Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00
Technical metadata and extraction receipts
Stable ID: use-case-mapping-amp-20261007-issue11-enfusion-nch-clinical
- field
- links:assessed_by:amp-oncology-rna-20261007-protocol-enfusion-nch-clinical
- value
- amp-oncology-rna-20261007-protocol-enfusion-nch-clinical
- relevance
- direct
- endpoint
- Retrospective sensitivity among 67 ensemble-ascertained clinically relevant fusions in a 229-sample paediatric cancer/haematologic cohort, for STAR-Fusion and Arriba
- rationale
- A real clinical cohort with ensemble-ascertained clinically relevant fusions directly measures fusion-detection sensitivity in a clinical population, the declared endpoint; the ascertainment denominator is not an independent exhaustive truth set.
- constraints
- Inspect every linked evaluation's source locator and preserved conflicts before citing a result.; Do not combine this mapping's evaluations with any other protocol's results.
- limitations
- Ascertainment is from the optimized EnFusion pipeline; denominator is not an independent exhaustive truth set.; Only a subset orthogonally confirmed; the endpoint does not quantify novel fusion generalization or patient outcomes.; Do not combine with duplicate Seraseq measurements.
- revision
- 1
- reason
- Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365).
- citation locators
- source id: amp-oncology-rna-20261007-source-pmc8642973; locator: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- source locator
- amp-oncology-rna-20261007-source-pmc8642973: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- review
- method: automated-source-review; reviewer: codex; claude-sonnet; reviewer note: Claude Sonnet AMP-integration worker, bounded transcription of Codex-checked primary values; independently reviewed by Codex (workbench/amp-supervision/primary-review.md, integration-review-corrections.md); reviewed at: 2026-10-07T13:38:59Z; note: Bounded primary-source transcription, independently Codex-checked. No new model execution, independent experimental reproduction, qualified human scientific review or clinical validation.
- reviewed evaluations
- amp-oncology-rna-20261007-nch-eval-arriba; amp-oncology-rna-20261007-nch-eval-star-fusion
- pins
- record id: amp-oncology-rna-20261007-nch-eval-arriba; fields: status; links; attributes.origin; attributes.comparison; sha256: dc47a5e8696fc4848d9d83ed459034a382c91a15633e27042e446440a86b169a; record id: amp-oncology-rna-20261007-nch-eval-star-fusion; fields: status; links; attributes.origin; attributes.comparison; sha256: b50199a8a2b92409ac64713dbc14692bc718b3d3638f9b5c14270ac98e6722dc; record id: amp-oncology-rna-20261007-nch-result-arriba-clinically-relevant-fusions-called; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 066f1fdfd83afc161cb600719fbc6a5100d019f3b1f62759ecb729d4bff669a4; record id: amp-oncology-rna-20261007-nch-result-arriba-sensitivity-among-ensemble-ascertained-clinically-relevant-fusions; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: c2ac8dea66a6f8f9bfad36885e8ec669031c1773d18c0b234668932b723627f7; record id: amp-oncology-rna-20261007-nch-result-star-fusion-clinically-relevant-fusions-called; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 4c25977928b165c55966c7fe46f79743d0d9e27b21b2b14018ab9e6be7cafe3a; record id: amp-oncology-rna-20261007-nch-result-star-fusion-sensitivity-among-ensemble-ascertained-clinically-relevant-fusions; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d81d02b2375a73774255ba516745ce4a03eac11f5101b570c493e0e4de47913d; record id: amp-oncology-rna-20261007-protocol-enfusion-nch-clinical; fields: status; name; description; facets; source_ids; links; attributes; sha256: 5ffa7299387a417f30d9ac120d4782a90bf51335ca63c880304bc6a08e972df9; record id: amp-oncology-rna-20261007-source-pmc8642973; fields: status; attributes.artifact_sha256; sha256: 8756f3d2c4ba60254cb9003e93789cb6d48623573fe1cf5440f7a90ce98037fa; record id: use-case-tumour-rna-fusion-detection; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 813ef5e1275c5b78b486810d5445b67c9069bf366d78399aa2098727d56b2d15